Xuehua Sun
- Hepatology top 5%
- Hepatitis C virus research 15
- Liver physiology and pathology 5
- Immunology top 10%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 3
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 6
-
- Hepatitis B Virus Studies 20
- Liver Disease Diagnosis and Treatment 15
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Cited by
- HepatologyImmunologyPharmacology
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaHong KongSouth Korea
In The Last Decade
Xuehua Sun
47 papers receiving 872 citations
Peers
Comparison fields: 5 of 91
- Hepatology 186
- Immunology 222
- Pharmacology 89
- Cancer Research 123
- Epidemiology 245
Countries citing papers authored by Xuehua Sun
This map shows the geographic impact of Xuehua Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuehua Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuehua Sun more than expected).
Fields of papers citing papers by Xuehua Sun
This network shows the impact of papers produced by Xuehua Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuehua Sun. The network helps show where Xuehua Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuehua Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 18 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 16 | |
| 6 | Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma | 2022 | 15 |
| 7 | 2021 | 8 | |
| 8 | 2021 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 27 | |
| 12 | 2020 | 33 | |
| 13 | 2020 | 5 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 8 | |
| 17 | 2019 | 1 | |
| 18 | 2018 | 40 | |
| 19 | 2013 | 8 | |
| 20 | Clinical Study on Chronic Hepatitis C Treated by "Liver-Clearing Granule | 2003 | 2 |
About Xuehua Sun
Xuehua Sun is a scholar working on Hepatology, Pharmacology and Epidemiology, having authored 49 papers that have together received 877 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (20 papers), Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (15 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Immune Cell Function and Interaction (6 papers), Liver physiology and pathology (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Hepatology (186 citations), Immunology (222 citations) and Pharmacology (89 citations). Xuehua Sun has collaborated with scholars based in China, Hong Kong and South Korea. Frequent co-authors include Yueqiu Gao, Xiaoni Kong, Man Li, Chang Yu, Zhuo Yu, Xiaojun Zhu, Bingrui Wang, Zhenhua Zhou, Jie Zhao and Hailong Wu. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.